Posts

Tim Sweeney, MD, PhD, is co-founder and CEO of Inflammatix, discusses the company’s success with non-dilutive funding.

Ram May-Ron, Managing Partner of the FreeMind Group, Dongkyu “Theirry” Uh, President of Daewoong Innovation Holdings, and Ayal Ronen, Chief Business Officer of the FreeMind Group discuss our new venture capital fund, FreeMind Investments.

Ayal Ronen of the FreeMind Group gave a demonstration of a new shared work space we have developed and how it is propelling grant writing into the digital age.

View Slide Deck

Dr. Charles Cywin of the National Institute of Neurological Disorders and Stroke spoke about the programs available to support neuroscience translational research.

View Slide Deck

Dr. Matthew Portnoy of the National Institutes of Health gave updates on the Small Business Innovation Research and Small Business Technology Transfer Programs.

View Slide Deck

Dennis Ford of Life Science Nation shared tips on interacting with investors as you work on a strategic method of fundraising for your R&D.

View Slide Deck

John Nobile of Tangen Biosciences talked about his company’s process in achieving their recent contract with BARDA.


Dr. Joe Larsen of the Biomedical Advanced Research and Development Authority discussed current CBRN threats and BARDA’s role in developing and stockpiling countermeasures.

View Slide Deck